GlassScriptPhysician profile
Erica M Dastrup
NPI 1265915524
$3,541.94
in general payments reported to CMS, 2019-2025
16 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $1,877 · 2023: $620 · 2024: $568 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.09 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,057.10 | 2021-2024 | Azure Xt Dr Mri Surescan, Venaseal, Linq II |
| Janssen Pharmaceuticals, INC | $293.16 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $222.11 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $188.01 | 2022-2023 | Camzyos |
| United Therapeutics Corporation | $186.27 | 2024-2025 | Tyvaso, Tyvaso |
| Novartis Pharmaceuticals Corporation | $176.76 | 2024-2025 | |
| Boston Scientific Corporation | $98.90 | 2021-2024 | Latitude Communicator Power Supply, Rhythmia Mapping System |
| Novo Nordisk INC | $92.42 | 2025 | Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $47.66 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $45.36 | 2024-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $29.89 | 2023 | Mitraclip |
| Kiniksa Pharmaceuticals International, Plc | $24.22 | 2024 | Arcalyst |
| Biotronik INC. | $22.84 | 2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Pfizer INC. | $21.00 | 2025 | |
| Amgen INC. | $18.85 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $17.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erica Dastrup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.